HSIC.NASDAQHenry Schein INC

DEF 14A: Henry Schein's 2024 Proxy Statement: Key Proposals and Executive Compensation Details

Sentiment:

Proxy Statement


Henry Schein's 2024 proxy statement outlines proposals for director elections, stock incentive plan amendments, executive compensation, and auditor ratification, providing insights into corporate governance and executive pay practices.

Worse than expectedThe company's actual 2023 non-GAAP diluted EPS was $4.14, below the target of $5.06, resulting in a 0% payout for the Company Financial/EPS Goal portion of the PIP award.

Summary

  • Henry Schein's proxy statement details key proposals for the 2024 Annual Meeting of Stockholders, including the election of thirteen directors.
  • A proposal to amend and restate the company's 2020 Stock Incentive Plan, renaming it the 2024 Stock Incentive Plan, is under consideration.
  • Stockholders will also vote on the approval of the 2023 compensation paid to the company's Named Executive Officers and the ratification of BDO USA, P.C. as the independent registered public accounting firm for the fiscal year ending December 28, 2024.
  • The Board of Directors has fixed March 22, 2024, as the record date for determining stockholders entitled to notice of and to vote at the Annual Meeting.
  • As of the record date, 128,481,162 shares of common stock were outstanding.
  • The company is taking advantage of SEC rules allowing issuers to furnish proxy materials to stockholders on the Internet.
  • The Annual Meeting will be held virtually on May 21, 2024, at 10:00 a.m., Eastern Daylight Time.
  • The proxy statement also includes details on corporate governance, executive compensation, and security ownership of certain beneficial owners and management.

Sentiment

Score: 6

Explanation: The document is largely factual and informative, but the cybersecurity incident and lower than expected EPS temper the overall sentiment.

Positives

  • The company has a strong, values-based culture and is committed to environmental, social, and governance (ESG) initiatives.
  • The company provides opportunities for Team Schein Members (TSMs) to develop personally and professionally.
  • The company has a long history of a purpose-driven model that engages its five key stakeholders.
  • The company has a continuous listening program to garner feedback from TSMs on their employee experience.
  • The company has a director retirement policy to ensure a balance of experience and new perspectives on the Board of Directors.

Negatives

  • The company experienced a cybersecurity incident in October 2023, which primarily affected the operations of its North American and European dental and medical distribution businesses.
  • The company's actual 2023 non-GAAP diluted EPS was $4.14, below the target of $5.06, resulting in a 0% payout for the Company Financial/EPS Goal portion of the PIP award.
  • Approximately 14% of the company's employees are subject to collective bargaining agreements.

Risks

  • The company faces risks related to regulatory, corporate compliance, and cybersecurity matters.
  • The company's strategic and business development plans carry inherent risks.
  • The company's response to climate risk and other relevant strategic sustainability risks could impact its operations, supply chain, and communities.
  • The company's compensation policies and practices for its executive officers and other employees could create risks that are reasonably likely to have a material adverse effect on the company.

Future Outlook

The company aims to continue its digital transformation and increase focus on higher-growth, higher-margin businesses through its BOLD+1 Strategic Plan.

Management Comments

  • Stanley M. Bergman, Chairman and Chief Executive Officer, looks forward to discussing the company's plans for the future at the Annual Meeting.

Industry Context

The document provides insights into Henry Schein's compensation practices, which are benchmarked against a peer group of companies engaged in the distribution and/or manufacturing of healthcare products or industrial equipment and supplies.

Comparison to Industry Standards

  • The company benchmarks its executive compensation against a peer group including AmerisourceBergen Corporation, Baxter International Inc., Cardinal Health, Inc., DaVita Inc., Dentsply Sirona Inc., Fastenal Company, Laboratory Corporation of America Holdings, MSC Industrial Direct Co., Inc., Owens & Minor, Inc., Patterson Companies, Inc., Quest Diagnostics, Inc., W.W. Grainger, Inc. and WESCO International Inc.
  • The company generally targets compensation at the median of the market and calibrates both annual and long-term incentive opportunities to generate less-than-median awards when goals are not fully achieved and greater-than-median awards when goals are exceeded.
  • The company's compensation program changes reflect preferences of its stockholders and are aligned with best market practices.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Amendment to Corporate Governance GuidelinesThe Board of Directors amended the Companys Corporate Governance Guidelines to include a director time commitment policy.March 2024The policy aims to ensure directors can devote sufficient time to their duties and responsibilities effectively.

Related Party Transactions

  • Mr. Connett has one family member and Mr. Breslawski has two family members who are non-executive employees of the Company or its subsidiaries and where such employees aggregate compensation for fiscal 2023 was in excess of $120,000.
  • The compensation paid to each such family member is comparable to other Company employees at a similar level.
  • The Audit Committee reviewed, approved and ratified those related-party transactions for fiscal 2023, including the total compensation paid to such individuals in fiscal 2023.

Stakeholder Impact

  • The company's executive compensation program is designed to align the interests of its named executive officers with the long-term interests of its stockholders.
  • The company is committed to creating shared value for society through its sustainability approach and ESG efforts.
  • The company recognizes the changes in how and where TSMs work, and the expectations of our team members to still feel connected to our values-based culture.

Next Steps

  • Stockholders are urged to cast their vote on the proposals outlined in the proxy statement.
  • The company will continue to engage with stockholders to ensure its programs reflect priorities that are important to them.
  • The company anticipates issuing its 2023 Sustainability and CSR Report during the second quarter of fiscal 2024.

Key Dates

DateDescription
2019-12-29Start date for some historical equity awards data.
2020-12-26End date for some historical equity awards data.
2020-12-27Start date for some historical equity awards data.
2021-12-25End date for some historical equity awards data.
2021-12-26Start date for some historical equity awards data.
2022-12-31End date for some historical equity awards data.
2023-01-01Start date for some historical equity awards data.
2023-12-30End date for some historical equity awards data.
2024-03-22Record date for determining stockholders entitled to notice of and to vote at the Annual Meeting.
2024-05-21Date of the 2024 Annual Meeting of Stockholders.
2024-12-28Fiscal year end date for which BDO USA, P.C. is proposed as the independent registered public accounting firm.
2025Year in which directors elected at the 2024 Annual Meeting will have terms expiring.
2034-03-31End date for granting awards under the 2024 Stock Incentive Plan.

Keywords

Corporate governance, Executive compensation, Stock incentive plan, Board of Directors, Annual meeting, Proxy statement, ESG, Sustainability, Directors, Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.